The histological findings were those of mixed pattern of chronic hepatitis with cholestasis and mild periportal fibrosis, features consistent with drug-induced liver injury
Liraglutide (marketed as Victoza for diabetes, Saxenda for obesity) was the first GLP-1 agonist approved for chronic weight management (FDA 2014), while semaglutide (Ozempic/Wegovy/Rybelsus) arrived later with improved pharmacokinetics and substantially greater efficacy
Whilst clinical evidence suggests GLP-1 medications can be used effectively in many older people, careful patient selection, appropriate dosing, and vigilant monitoring are essential
This can be due to various reasons, which will be discussed below
Jensterle, M., Kocjan, T., Kravos, N
Magnesium helps manage our insulin and carbohydrate metabolism, is involved in our bodys ability to release insulin and may also help our cells use insulin better